What is it? · Laboratory-made kratom-related derivative

What is MGM-15?

MGM-15 is the shorthand name for dihydro-7-hydroxymitragynine. It is a distinct laboratory-made derivative, rather than a strain, a leaf color, or another name for ordinary mitragynine extract.

MGM-15Dihydro-7-hydroxymitragynine

Category

Laboratory-made kratom-related derivative

Also called

Dihydro-7-hydroxymitragynine

Key distinction

Ingredient identity and manufacturing process matter more than a trade name.

MGM-15: advised against.

DEA identifies MGM-15 among the potent opioid compounds addressed by its temporary scheduling action. We advise against products containing it. The available scientific and regulatory record does not supply a dependable retail-product comparison to leaf powder or mitragynine tablets.

From leaf to ingredient

Where does it come from?

Its chemical structure differs from both mitragynine and 7-OH. This is a change to the molecule, rather than simply grinding leaf or extracting the alkaloids already present. A retail brand name does not establish the full ingredient list.

Read the label

What makes it different?

MGM-15 and MGM-16 are separate compounds. Their similar names do not establish equal contents, effects or strength. Neither name should be used as a synonym for conventional leaf-derived mitragynine.

What is its legal status?

MGM-15 and covered forms were placed in federal Schedule I effective August 26, 2026. The October 14 companion notice preserves the existing approach pending a later action. State and local rules may add separate restrictions.

Check federal, state and local law

Read the originals

Sources & further reading

Legal sources reviewed: November 17, 2026.

Responsible-use guidance covers interactions, dependence and other precautions.